200 related articles for article (PubMed ID: 30022679)
21. Diagnostic values of serum IL-10 and IL-17 in rheumatoid arthritis and their correlation with serum 14-3-3η protein.
Qu CH; Hou Y; Bi YF; Han QR; Jiao CH; Zou QF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1899-1906. PubMed ID: 30915732
[TBL] [Abstract][Full Text] [Related]
22. Serologic Diagnosis of Rheumatoid Arthritis.
Allard-Chamard H; Boire G
Clin Lab Med; 2019 Dec; 39(4):525-537. PubMed ID: 31668267
[TBL] [Abstract][Full Text] [Related]
23. 14-3-3η Protein in serum and synovial fluid correlates with radiographic damage and progression in a longitudinal evaluation of patients with established rheumatoid arthritis.
Hammam N; Salah S; Kholef EF; Moussa EM; Marotta A
Mod Rheumatol; 2020 Jul; 30(4):664-670. PubMed ID: 31242798
[No Abstract] [Full Text] [Related]
24. Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers.
Carrier N; de Brum-Fernandes AJ; Liang P; Masetto A; Roux S; Biln NK; Maksymowych WP; Boire G
RMD Open; 2020 May; 6(1):. PubMed ID: 32371434
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers for the diagnosis and treatment of rheumatoid arthritis - a systematic review.
Abdelhafiz D; Baker T; Glascow DA; Abdelhafiz A
Postgrad Med; 2023 Apr; 135(3):214-223. PubMed ID: 35275765
[TBL] [Abstract][Full Text] [Related]
26. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.
Takeuchi T; Miyasaka N; Inui T; Yano T; Yoshinari T; Abe T; Koike T
Arthritis Res Ther; 2017 Sep; 19(1):194. PubMed ID: 28865493
[TBL] [Abstract][Full Text] [Related]
27. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
28. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers in Rheumatoid Arthritis.
Atzeni F; Talotta R; Masala IF; Bongiovanni S; Boccassini L; Sarzi-Puttini P
Isr Med Assoc J; 2017 Aug; 19(8):512-516. PubMed ID: 28825772
[TBL] [Abstract][Full Text] [Related]
30. Serum 14-3-3η is a Marker that Complements Current Biomarkers for the Diagnosis of RA: Evidence from a Meta-analysis.
Wu Y; Dai Z; Wang H; Wang H; Wu L; Ling H; Zhu Y; Ye D; Wang B
Immunol Invest; 2022 Jan; 51(1):182-198. PubMed ID: 32967487
[TBL] [Abstract][Full Text] [Related]
31. Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.
Boer AC; Boonen A; van der Helm van Mil AHM
Arthritis Care Res (Hoboken); 2018 Jul; 70(7):987-996. PubMed ID: 29266813
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers in Rheumatoid Arthritis, what is new?
Gavrilă BI; Ciofu C; Stoica V
J Med Life; 2016; 9(2):144-8. PubMed ID: 27453744
[TBL] [Abstract][Full Text] [Related]
33. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C
Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263
[TBL] [Abstract][Full Text] [Related]
34. A novel bedside test for ACPA: the CCPoint test is moving the laboratory to the rheumatologist's office.
Zandman-Goddard G; Soriano A; Gilburd B; Lidar M; Kivity S; Kopilov R; Langevitz P; Shoenfeld Y; Agmon-Levin N
Immunol Res; 2017 Feb; 65(1):363-368. PubMed ID: 27470303
[TBL] [Abstract][Full Text] [Related]
35. High titer of anti-citrullinated peptide antibody is a risk factor for severe carotid atherosclerotic plaque in patients with rheumatoid arthritis: the TOMORROW study.
Okano T; Inui K; Sugioka Y; Sugioka K; Matsumura Y; Takahashi S; Tada M; Mamoto K; Wakitani S; Koike T; Nakamura H
Int J Rheum Dis; 2017 Aug; 20(8):949-959. PubMed ID: 28627096
[TBL] [Abstract][Full Text] [Related]
36. Multiple biomarker approach for the diagnosis and therapy of rheumatoid arthritis.
Savvateeva E; Smoldovskaya O; Feyzkhanova G; Rubina A
Crit Rev Clin Lab Sci; 2021 Jan; 58(1):17-28. PubMed ID: 32552254
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
Meyer PWA; Ally MTM; Hodkinson B; Anderson R; Tikly M
Rheumatol Int; 2018 Jun; 38(6):993-1001. PubMed ID: 29713794
[TBL] [Abstract][Full Text] [Related]
38. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study.
Berendsen MLT; van Maaren MC; Arts EEA; den Broeder AA; Popa CD; Fransen J
J Rheumatol; 2017 Sep; 44(9):1325-1330. PubMed ID: 28668802
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic significance of combined detection of rheumatoid factor and anticyclic citrullinated peptide antibodies in rheumatoid arthritis].
Mu R; Sun XY; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):498-500. PubMed ID: 16224521
[TBL] [Abstract][Full Text] [Related]
40. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
Front Immunol; 2018; 9():876. PubMed ID: 29740454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
